MiroBio is a biotechnology company focused on developing innovative therapies that modulate the immune system to treat various diseases, particularly cancer and autoimmune disorders. The company utilizes its proprietary platform to identify and enhance immune checkpoint modulators, aiming to improve patient outcomes.